Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Catheter ablation versus antiarrhythmic drug therapy for symptomatic idiopathic ventricular premature beats/ventricular tachycardia
2018-001518-13Phase 4Terminated
- Sponsor
- Cardiologie Zwolle
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sotalol, flecainide and verapamil in Premature ventricular complexes (PVC) and ventricular tachycardia (VT) (3 arms), sponsored by Cardiologie Zwolle. Primary endpoint: Successful therapy after 3 months. Started Aug 2018; status: terminated.
02
Drugs
sotalolflecainideverapamil
03
Conditions
Premature ventricular complexes (PVC)ventricular tachycardia (VT)
Beyond the preview
Go deeper on 2018-001518-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001518-13.